Washington University - Siteman Cancer Center

Washington University - Siteman

Washington University School of Medicine and Siteman Cancer Center is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) for both autologous and allogeneic transplants; adult and pediatric allogeneic and autologous hematopoietic progenitor cellular therapy and immune effector cellular therapy.

Washington University physicians have performed nearly 10,000 hematopoietic cell transplantations since 1982. Siteman is also a leader in unrelated donor transplants. The procedure has been offered since 1992 and Siteman performs nearly 100 every year, making the program one of the largest in the world.

Washington University’s Center for Gene and Cellular Immunotherapy offers vector-based gene therapy and cellular therapies and has capabilities to manufacture CAR-T and NK based therapies in our state-of-art GMP facility. Our physicians perform over 75 CAR-T infusions each year, totaling nearly 300 CAR-T infusions since our cell therapy program inception in 2018.

Siteman is one of only three institutions nationwide to hold a Specialized Program in Research Excellence (SPORE) grant in leukemia from the National Institutes of Health (NIH).